| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 10/25/2001 | CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 10/25/2001 | CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 10/24/2001 | EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors |
| 10/24/2001 | EP0749419B1 Oxime derivatives and their use as pesticides |
| 10/24/2001 | CN1319008A Hydroxamate-containing cysteine and serine protease inhibitors |
| 10/18/2001 | WO2001077069A1 Naphthamide neurokinin antagonists for use as medicaments |
| 10/18/2001 | US20010031896 By reacting with 2,2,2-trifluoroethylformate in an optionally buffered solvent; by-product inhibition |
| 10/18/2001 | US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines |
| 10/16/2001 | CA2196309C Processes and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-tetrahydropyrimidin-2(1h)-one |
| 10/16/2001 | CA2015470C Fluorinated arachidonic acid derivatives |
| 10/11/2001 | WO2001074757A1 Process for the selective n-formylation of n-hydroxylamines |
| 10/11/2001 | CA2403529A1 Process for the selective n-formylation of n-hydroxylamines |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001070673A2 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 09/27/2001 | WO2001070664A2 Lipoxin analogs and methods for the treatment of periodontal disease |
| 09/27/2001 | WO2001014390A3 METABOTROPIC GLUTAMATE RECEPTOR LIGAND DERIVATIVES AS NAALADase INHIBITORS |
| 09/27/2001 | CA2404002A1 Inhibitors of histone deacetylase |
| 09/27/2001 | CA2401870A1 Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-.alpha. |
| 09/26/2001 | EP1135364A1 Substituted oximes |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | US20010023240 Compounds and compositions for delivering active agents |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/19/2001 | CN1313776A Therapeutic agents for allergic diseases |
| 09/19/2001 | CN1313278A Process for synthesizing anidoxime |
| 09/18/2001 | US6291709 Solid supported synthesis of hydroxamic acids |
| 09/18/2001 | US6291520 Hydroxamic acid and N-hydroxyurea derivatives and their use |
| 09/18/2001 | US6291413 O-substituted N,N-diacylhydroxylamine bleach activators and compositions employing the same |
| 09/13/2001 | US20010021791 Cyclopropyl phenyl ketone compound |
| 09/13/2001 | US20010021718 Antiscarring agent |
| 09/12/2001 | CN1070845C Benzamidoxime derivative, process for production thereof, and agrotoricultural bactericide |
| 09/11/2001 | US6288261 Drugs for inhibition of enzymes |
| 09/11/2001 | US6288063 Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
| 09/06/2001 | US20010020114 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 09/05/2001 | EP0873304B1 Metalloproteinase inhibitors |
| 09/05/2001 | EP0777646B1 Metalloproteinase inhibitors |
| 09/05/2001 | CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 09/04/2001 | US6284914 Highly water-soluble metalloproteinase inhibitors |
| 09/04/2001 | US6284796 Naphthamidine compounds |
| 08/30/2001 | US20010018521 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 08/29/2001 | EP0889877B1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS |
| 08/29/2001 | CN1310704A Hydroxamic acid derivatives and medicinal utilization thereof |
| 08/28/2001 | US6281245 Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof |
| 08/28/2001 | US6281003 Enzymatic synthesis of optically active hydroxamic acids and their conversion to optically active primary amines by a lossen rearrangement |
| 08/23/2001 | WO2001060803A1 Fused imidazolium derivatives |
| 08/23/2001 | WO2001060785A1 Acetal hydroxylamine compounds |
| 08/22/2001 | CN1309634A Hydrazine derivs. |
| 08/22/2001 | CN1309632A Salts of N-tert-butylhydroxylamine |
| 08/21/2001 | CA2196845C Hydroxamic acid compounds |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/15/2001 | CN1308611A Antihistaminic piperidine derivatives and intermediates for the preparation thereof |
| 08/14/2001 | US6274733 Process and intermediates in the synthesis of 5-(3-[exo-bicyclo[2.2.1]hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6-tetrahydro-pyrimidin-2(1H)-one |
| 08/09/2001 | WO2001056976A1 Paracyclophane-based epoxidation catalysts |
| 08/08/2001 | EP1121118A1 Formamides as therapeutic agents |
| 08/08/2001 | CN1307564A Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them |
| 08/08/2001 | CN1307553A Process for solid phase synthesis of aldehyde ketone oxime, amine, hydroxamic acid and alpha, beta-unsaturated carboxylic acid and aldehyde compounds |
| 08/07/2001 | US6271245 Hydroxamic acid derivatives |
| 08/02/2001 | WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF |
| 08/02/2001 | WO2001055096A1 Method for producing n-alkoxy-n-alkylamides |
| 08/02/2001 | DE10004044A1 Epoxidierungskatalysatoren auf Paracyclophanbasis Epoxidation on Paracyclophanbasis |
| 08/01/2001 | CN1306508A Hydroxamic acid derivatives as inhibitors or prodn. of human CD23 and of TNF release |
| 07/25/2001 | EP0854861B1 Oxyamino oxime ethers, methods and intermediate products for their production, and agents containing them and used for controlling harmful fungi and pests |
| 07/25/2001 | EP0854860B1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 07/19/2001 | WO2001051456A2 Antibacterial agents |
| 07/19/2001 | US20010008947 Administering derivative of 2-amino-4-phenyl-4-oxo-butyric acid which acts as kynureninase/kynurenine-3-hydroxylase enzyme inhibitor; neurodegenerative diseases |
| 07/19/2001 | CA2397575A1 Antibacterial agents |
| 07/18/2001 | EP1115697A1 Unsaturated hydroximic acid derivatives as parp inhibitors |
| 07/18/2001 | EP1115390A1 Hydroxamate-containing cysteine and serine protease inhibitors |
| 07/12/2001 | WO2001049657A1 2-`3-amino-4-(n-hydroxyamino)-succinylamino-acetamides for use as cd23 formation inhibitors |
| 07/11/2001 | EP1113789A1 Method and composition for treatment of inflammatory bowel disease |
| 07/11/2001 | CN1303444A Mineral collector compositions of fatty hydroxamic acid in admixture with oil and process of making same |
| 07/10/2001 | US6258822 Urokinase inhibitors |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/05/2001 | WO2001047901A1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors |
| 07/03/2001 | US6255489 Method for producing (hetero)aromatic hydroxylamines |
| 06/27/2001 | EP1109777A1 N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them |
| 06/27/2001 | EP1109545A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
| 06/27/2001 | EP0876332B1 Phenylacetic acid derivatives, process and intermediate products for use in producing them and agents containing them |
| 06/26/2001 | US6252083 Fungicides, insecticides, nematocides |
| 06/26/2001 | US6251949 Oxime derivatives, hydrazone derivatives and use thereof |
| 06/26/2001 | US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy |
| 06/26/2001 | US6251940 Administering to the mammal suffering from a diseases responsive to inhibit monocyte and/or macrophase and/or lymphocyte activation and of lymphocyte proliferation an amide derivative |
| 06/26/2001 | US6251574 Color photographic developer concentrate |
| 06/21/2001 | WO2001044189A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/21/2001 | WO2001044188A1 Hydroxamic acid derivatives as matrix metalloproteinase (mmp) inhibitors |
| 06/13/2001 | EP0863132B1 Ketonitrile derivatives and antibacterial agent and drug containing the same |
| 06/07/2001 | WO2001040164A1 A multistage process for the preparation of highly pure deferoxamine mesylate salt |
| 06/07/2001 | CA2392925A1 A multistage process for the preparation of highly pure deferoxamine mesylate salt |
| 06/06/2001 | CN1298299A Antibacterial agents |
| 06/05/2001 | US6242644 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/05/2001 | US6242615 Amidation of acid containing compounds; useful in inhibiting tumor necrosis factor and metalloproteinases |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242495 Compounds and compositions for delivering active agents |
| 05/31/2001 | WO2001038561A1 Methods of use of peptide deformylase inhibitors as novel antibacterial agents |
| 05/31/2001 | WO2001038322A1 Inhibitors of histone deacetylase |
| 05/30/2001 | EP1102739A1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 05/30/2001 | CN1066436C Cyclohexanes and cyclohexenes derivs. |
| 05/29/2001 | US6239151 Compounds as inhibitor of tumor necrosis factor alpha release |
| 05/25/2001 | WO2001036374A2 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 05/24/2001 | US20010001799 Anticoagulant |